SCHEMBL2940251

SCHEMBL2940251

CC1(C)C(=O)N(c2ccc(SC(F)(F)F)cc2)C(=O)N1Cc1cnc(Cl)s1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3726795 0.94 IGF1R (0.60) IGF1R
SCHEMBL1130587 0.80 IGF1R (1.00) IGF1R
SCHEMBL2943071 0.79 IGF1R (0.80) IGF1R
SCHEMBL2931813 0.79 IGF1R (0.74) IGF1R
SCHEMBL2939981 0.79 IGF1R (1.00) IGF1R
SCHEMBL2997912 0.78 IGF1R (0.59) IGF1R
SCHEMBL13039149 0.78 IGF1R (0.69) IGF1R
SCHEMBL2934949 0.77 IGF1R (0.60) IGF1R
SCHEMBL2939123 0.76 IGF1R (0.67) IGF1R
SCHEMBL13039168 0.76 IGF1R (0.63) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed